CompletedNCT00000239
Long-term buprenorphine use and sensitivity to opioids
About this title
Read the official source — NCT00000239Medication studyAges 0+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 0 years.
- Listed locations
- BurlingtonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 0
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 0 Years
- Official registry ID
- NCT00000239
- Official title
Show the full official title
Buprenorphine Pharmacology Related to Addiction Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Burlington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine.
Who was this study for?
Listed age limits: from 0 years.
